Targeting the exosomal CaMK2A-ZDHHC3-GPX4 pathway reprograms tumor-associated macrophages and enhances anti-PD-1/PD-L1 immunotherapy in gastric cancer. - Chen Z; Huang H; Shen Y; Yamamoto M; Tsukamoto T; Nomura S; Jiang T; Xu Z; Li Z (International journal of biological sciences, 2026)